New Preclinical Tool May Help Predict Heart Problems in ATTR Amyloidosis

New Preclinical Tool May Help Predict Heart Problems in ATTR Amyloidosis

285763

New Preclinical Tool May Help Predict Heart Problems in ATTR Amyloidosis

Investigating how plasma from people with transthyretin (ATTR) amyloidosis affects heart cells from rats may help researchers predict future heart-related health events and deaths in these patients, a study suggests. The findings were published in Clinical Research in Cardiology, in the study “Impaired in vitro growth response of plasma-treated cardiomyocytes predicts poor outcome in patients with transthyretin amyloidosis.” ATTR amyloidosis is characterized by the abnormal buildup of the protein transthyretin in multiple organs. When these deposits…

You must be logged in to read/download the full post.